| |
Optimal Frontline Therapy of Myeloma |
, , , , , |
|
On-Demand Webcast |
| |
What Are the Latest Strategies for Relapsed CLL and What Is on the Horizon? |
, , , , , |
|
On-Demand Webcast |
| |
Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023 |
, , , , , |
|
On-Demand Webcast |
| |
Effective Risk Stratification and Expert Treatment Selection Advice for Patients with Myelodysplastic Syndromes |
, , , , , |
|
On-Demand Webcast |
| |
How do we choose among non-CAR-T options for patients with recurrent aggressive lymphoma |
, , , , , |
|
On-Demand Webcast |
| |
Targeted Treatment for Mantle Cell Lymphoma: Reimagining First-Line Therapy |
, , , , , |
|
On-Demand Webcast |
| |
First Line Treatment of CLL/SLL with Bruton 's Tyrosine Kinase Inhibitors: Seeking Lasting Results |
, , , , , |
|
On-Demand Webcast |
| |
Managing Relapsed/Refractory Follicular Lymphoma: Novel Therapeutic Strategies Across Treatment Lines |
, , , , , |
|
On-Demand Webcast |
| |
Antibody drug conjugates – where and when to use them in Hodgkin Lymphoma |
, , , , , |
|
On-Demand Webcast |
| |
Multi-Cancer Early Detection Tests: Novel Strategies to Improve Cancer Screening in Primary Care Practice |
, , , , |
Oncology |
On-Demand Webcast |
